[The significance of non-Ph chromosome in chronic myelogenous leukemia].
作者信息
Wang Z, Mi Y C
机构信息
State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China.
出版信息
Zhonghua Xue Ye Xue Za Zhi. 2020 Aug 14;41(8):701-704. doi: 10.3760/cma.j.issn.0253-2727.2020.08.018.
Abstract
摘要
相似文献
1
[The significance of non-Ph chromosome in chronic myelogenous leukemia].[非费城染色体在慢性粒细胞白血病中的意义]
Zhonghua Xue Ye Xue Za Zhi. 2020 Aug 14;41(8):701-704. doi: 10.3760/cma.j.issn.0253-2727.2020.08.018.
2
Philadelphia chromosome-negative, bcr/abl-positive chronic myelogenous leukemia.费城染色体阴性、bcr/abl阳性慢性髓性白血病
J Nippon Med Sch. 2001 Aug;68(4):292-3. doi: 10.1272/jnms.68.292.
3
BCR/ABL rearrangement in Philadelphia chromosome negative CML patients.
J Med Assoc Thai. 2000 Mar;83 Suppl 1:S70-5.
4
Detection of the Philadelphia chromosome in paraffin-embedded tissue by fluorescence in situ hybridization.
Mod Pathol. 1994 Jun;7(5):565-9.
5
Analysis of Philadelphia chromosome-negative BCR-ABL-positive chronic myelogenous leukemia by hypermetaphase fluorescence in situ hybridization.采用高分辨中期荧光原位杂交技术分析费城染色体阴性的BCR-ABL阳性慢性粒细胞白血病
Ann Oncol. 1999 Aug;10(8):955-9. doi: 10.1023/a:1008349405763.
6
Amplification of the BCR/ABL fusion gene clustered on a masked Philadelphia chromosome in a patient with myeloblastic crisis of chronic myelocytic leukemia.一名慢性粒细胞白血病髓细胞危象患者中，BCR/ABL融合基因在一条隐匿的费城染色体上呈簇状扩增。
Cancer Genet Cytogenet. 2003 Jun;143(2):140-4. doi: 10.1016/s0165-4608(02)00854-3.
7
[New approach in the diagnosis and monitoring of treatment in chronic myelogenous leukemia].[慢性粒细胞白血病诊断与治疗监测的新方法]
Orv Hetil. 2004 Dec 26;145(52):2603-9.
8
BCR/ABL fusion located on chromosome 9 in chronic myeloid leukemia with a masked Ph chromosome.在伴有隐匿性费城染色体的慢性髓性白血病中，BCR/ABL融合基因位于9号染色体上。
Genes Chromosomes Cancer. 1995 Jun;13(2):133-7. doi: 10.1002/gcc.2870130210.
9
Comparison of bcr-abl protein expression and Philadelphia chromosome analyses in chronic myelogenous leukemia patients.
Am J Clin Pathol. 1996 Oct;106(4):442-8. doi: 10.1093/ajcp/106.4.442.
10
[The Philadelphia chromosome 30 years later].30年后的费城染色体
Rev Invest Clin. 1992 Jan-Mar;44(1):123-30.
本文引用的文献
1
European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia.欧洲白血病网络 2020 年治疗慢性髓性白血病的建议。
Leukemia. 2020 Apr;34(4):966-984. doi: 10.1038/s41375-020-0776-2. Epub 2020 Mar 3.
2
Clinical implications of clonal chromosomal abnormalities in Philadelphia negative cells in CML patients after treated with tyrosine kinase inhibitors.慢性粒细胞白血病患者经酪氨酸激酶抑制剂治疗后费城阴性细胞中克隆性染色体异常的临床意义
Cancer Genet. 2019 Oct;238:44-49. doi: 10.1016/j.cancergen.2019.07.008. Epub 2019 Jul 24.
3
Poor prognosis of chromosome 7 clonal aberrations in Philadelphia-negative metaphases and relevance of potential underlying myelodysplastic features in chronic myeloid leukemia.费城染色体阴性中期染色体 7 克隆异常预后不良及慢性髓性白血病潜在骨髓增生异常特征的相关性。
Haematologica. 2019 Jun;104(6):1150-1155. doi: 10.3324/haematol.2018.208801. Epub 2018 Dec 20.
4
Outcomes of 219 chronic myeloid leukaemia patients with additional chromosomal abnormalities and/or tyrosine kinase domain mutations.219 例伴有额外染色体异常和/或酪氨酸激酶结构域突变的慢性髓性白血病患者的结局。
Int J Lab Hematol. 2019 Feb;41(1):94-101. doi: 10.1111/ijlh.12928. Epub 2018 Oct 4.
5
Prognostic significance of additional chromosomal abnormalities at the time of diagnosis in patients with chronic myeloid leukemia treated with frontline tyrosine kinase inhibitors.初诊时伴有额外染色体异常的慢性髓性白血病患者采用一线酪氨酸激酶抑制剂治疗的预后意义。
Am J Hematol. 2018 Jan;93(1):84-90. doi: 10.1002/ajh.24943. Epub 2017 Nov 9.
6
Clonal chromosomal abnormalities appearing in Philadelphia chromosome-negative metaphases during CML treatment.慢性粒细胞白血病治疗期间出现在费城染色体阴性中期的克隆性染色体异常。
Blood. 2017 Nov 9;130(19):2084-2091. doi: 10.1182/blood-2017-07-792143. Epub 2017 Aug 23.
7
Additional cytogenetic abnormalities and variant t(9;22) at the diagnosis of childhood chronic myeloid leukemia: The experience of the International Registry for Chronic Myeloid Leukemia in Children and Adolescents.儿童慢性髓性白血病诊断时的附加细胞遗传学异常和变异 t(9;22)：儿童和青少年慢性髓性白血病国际登记处的经验。
Cancer. 2017 Sep 15;123(18):3609-3616. doi: 10.1002/cncr.30767. Epub 2017 May 12.
8
The effect of the additional cytogenetic abnormalities on major molecular response and BCR-ABL kinase domain mutations in long-term follow-up chronic myeloid leukemia patients, a cross sectional study.长期随访慢性髓性白血病患者中额外细胞遗传学异常对主要分子反应和BCR-ABL激酶结构域突变的影响：一项横断面研究
Leuk Lymphoma. 2017 Aug;58(8):1958-1962. doi: 10.1080/10428194.2016.1265112. Epub 2016 Dec 7.
9
Cytogenetic landscape and impact in blast phase of chronic myeloid leukemia in the era of tyrosine kinase inhibitor therapy.酪氨酸激酶抑制剂治疗时代慢性髓系白血病急变期的细胞遗传学特征和影响
Leukemia. 2017 Mar;31(3):585-592. doi: 10.1038/leu.2016.231. Epub 2016 Aug 18.
10
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia.2016 年版世界卫生组织髓系肿瘤和急性白血病分类。
Blood. 2016 May 19;127(20):2391-405. doi: 10.1182/blood-2016-03-643544. Epub 2016 Apr 11.
Zotero 插件